Barclays
MOBI

Barclays’s Mobia Medical MOBI Stock Holding History

Barclays’s Portfolio MOBI Stock Details MOBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
+896
New +$11.6K ﹤0.01% 4679

Other funds holding MOBI

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Barclays's MOBI Position: Q2 2026 in Review

Barclays opened a new position in Mobia Medical (MOBI) in Q2 2026: 896 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #4679 among its holdings.

42 funds tracked by Wall St. Rank hold MOBI as of Q2 2026.

  • Barclays held 896 shares of Mobia Medical worth $12K as of Q2 2026.
  • Mobia Medical was a new Barclays position in Q2 2026.
  • Mobia Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4679 holding.
  • 42 funds tracked by Wall St. Rank held Mobia Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.